China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Wednesday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Down 3.7 %

Shares of NYSE:CPHI opened at $0.23 on Wednesday. China Pharma has a 12 month low of $0.13 and a 12 month high of $0.60. The company’s fifty day simple moving average is $0.21 and its 200 day simple moving average is $0.22. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.